A new report examines and makes recommendations about the issue of self-monitoring of blood glucose (SMBG) in people with Type 2 diabetes who are not treated with insulin. The report was commissioned by the National Clinical Director for Diabetes in England. An NHS Diabetes working group was established with relevant stakeholders to undertake it, and they have now published their report…
On March 1, the first eye patients will enter an innovative new $132 million facility that expands the University of Michigan Health System’s capacity for eye care, research and education, and unites diabetes researchers as they work to accelerate the search for a cure and prevention of diabetes. The Brehm Tower at the W.K…
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) confirmed that the U.S. Food and Drug Administration (FDA) has set a new Prescription Drug User Fee Act (PDUFA) action date of March 12 for its review of the exenatide once weekly new drug application (NDA)…
Kimber L Stanhope, Jean Marc Schwarz, Nancy L Keim, Steven C Griffen, et al. Journal of Clinical Investigation. Ann Arbor: May 2009. Vol. 119, Iss. 5; p. 1322 (13 pages)
Available Formats:
[/images/common/ab.gif], Text+Graphics, Full Text – PDF
More documents may be available. Follow the link to view all documents in ProQuest for your search.